Clinical Trial: Study Comparing Bevacizumab + Temsirolimus Vs Bevacizumab + Interferon-Alfa In Advanced Renal Cell Carcinoma Subjects (INTORACT)
Sponsor and CollaboratorsWyeth
ContactContact: Pfizer CT.gov Call Center
1-800-718-1021
ClinicalTrials.gov_Inquiries@pfizer.com
Principal InvestigatorStudy Director: Pfizer CT.gov Call Center
ClinicalTrials.gov IdentifierNCT00631371